Mark Levy, MD
Vascular Surgery · Richmond, VANPI 1821193921
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $12,500 of the $16,609 with a category attached, or 75.3%. Corelink, LLC accounts for 75.3% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2020 at $12,793 and has fallen 98.8% since, to $150 in 2025.
Across 30 payments — averaging $553.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corelink, LLC$13K
- Medtronic$2K
- Silk Road Medical, Inc.$1K
- Penumbra, Inc.$271
- Shockwave Medical, Inc$178
- Abbott$150
- plus $138 from 2 others
What the payments were for
- Consulting fees$12,50075%
- Travel & lodging$1,2227%
- Food & beverage$2,88717%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corelink, LLC | 1 | $12,500 |
| Medtronic(2 entities) | 17 | $1,909 |
| Silk Road Medical, Inc. | 6 | $1,463 |
| Penumbra, Inc. | 2 | $271 |
| Shockwave Medical, Inc | 1 | $178 |
| Abbott | 1 | $150 |
| Bolton Medical Inc | 1 | $99 |
| Cook Medical LLC | 1 | $39 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$1,376
- ENROUTE Transcarotid Stent System$1,376
- ENHANCE Transcarotid Peripheral Access Kit$1,376
- ENROUTE 0.014 Guidewire$1,376
- ENDURANT IIS$696
- Endurant$464
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$178
- Signia$162
- XACT$150
- Valiant Navion$139
- Penumbra System$136
- Indigo System$135
- Valiant Captivia$124
How this compares
$16,609 in reported general payments places this provider in the 70th percentile of 143 vascular surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 37 | $277 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Richmond
- John DeitrickRichmond$684K
- Daniel NewtonRichmond$25K
- Michael AmendolaRichmond$18K
- Andrew LeakeRichmond$17K
- Michael MarcinczykRichmond$10K
- Jean PannetonVirginia Beach$1.3M
- Rasesh ShahChesapeake$465K
- David DexterNorfolk$404K
- Samuel SteermanVirginia Beach$252K
- Joseph BabrowiczFairfax$202K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.